Prosecution Insights
Last updated: August 18, 2026

Examiner: JOHNSON, KARA D

Tech Center 1600 • Art Units: 1600 1632 1657

This examiner grants 69% of resolved cases

Performance Statistics

69.1%
Allow Rate
+9.1% vs TC avg
528
Total Applications
+24.6%
Interview Lift
1133
Avg Prosecution Days
Based on 499 resolved cases, 2023–2026

Rejection Statute Breakdown

5.6%
§101 Eligibility
15.6%
§102 Novelty
41.7%
§103 Obviousness
29.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18742930 SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME Non-Final OA President and Fellows of Harvard College
18672600 METHODS AND COMPOSITIONS FOR THE PRODUCTION OF OLIGODENDROCYTE PROGENITOR CELLS Non-Final OA President and Fellows of Harvard College
18567448 PRINTABLE BIOINK AND METHOD OF PRINTING A TISSUE/ORGAN MODEL OR THERAPEUTIC CONSTRUCT Non-Final OA President and Fellows of Harvard College
17996943 METHOD FOR PRODUCING MILK LIKE PRODUCTS Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
17045459 3D SPATIALLY PATTERNED LYMPH NODE ON A MICROFLUIDIC DEVICE Non-Final OA University of Virginia Patent Foundation
18167467 Improved Cortical Spheroids and Methods of Making the Same Final Rejection The Florida State University Research Foundation, Inc.
18139694 SYNAPSE FORMATION AGENT Final Rejection Nipro Corporation
17693457 Methods And Compositions For Aesthetic And Cosmetic Treatment And Stimulating Hair Growth Non-Final OA Pluri Biotech Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month